Amgen Awards Three Golden Tickets for LabCentral Residency

Innovative Start-Up Companies Receive One-Year Free Lab Space CAMBRIDGE, Mass., March 28, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and LabCentral announced that Cocoon Biotech, Torus Therapeutics, and Holobiome are the winners of Golden Ticket awards. Sponsored by Amgen, the Golden Ticket awards underwrite the cost of a lab bench for a scientist from each organization to reside in LabCentral's open lab for one year. LabCentral is an innovative, shared laboratory space designed as a launchpad for premier high impact life-sciences and biotech startups. Amgen entered into a multi-year platinum-level sponsorship with LabCentral in late 2014. Amgen awarded a second Golden Ticket to Cocoo...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news